Dear Members,
Welcome to the May edition of the monthly LC newsletter!
This month’s issue includes key updates about various initiatives, details regarding upcoming events, along with highlights of recent LC, Member and Stakeholder activities to keep you informed.
Thank you for your continued support and contributions—happy reading!
Lymphoma Coalition is proud to endorse the newly launched CAR T Vision Coalition, an international effort committed to ensuring every eligible patient has the opportunity to be treated with the curative potential of CAR T-cell therapy. The coalition’s ambitious goal is to double the proportion of eligible patients receiving CAR T-cell therapy by 2030.
A new roadmap report outlines key barriers and a bold action plan focusing on three priorities: increasing awareness and understanding of CAR T-cell therapy, expanding delivery capacity, and developing sustainable financing models.
Members are invited to:
- Submit logos or endorsements for inclusion in coalition materials
- Review the CAR T Vision roadmap and consider joining the growing coalition of endorsers
- Share the campaign within their own networks
📩 Lorna Warwick, CEO, is part of the Steering Committee of this initiative. If you have questions about this project, you can connect with Lorna or you can direct your questions or express interest in endorsing the CAR T Vision by contacting the Secretariat team at: visionforcart@incisivehealth.com
Let’s work together to ensure more patients can access potentially life-saving treatment.